Group items tagged

Discover how to reduce health care disparities for vulnerable populations, including racial and ethnic minorities.

The infection control market research reports suggest increased demand of disinfection products due to rise in surgical proceedings, chronic diseases, and increased number of aging population.

Nerve repair market will grow at steady CAGR. Increasing aging population, chronic diseases and awareness will be the key drivers for the global industry.

Erectile dysfunction appears to be the most common problem affecting in men. It is also known as impotence in men. It is a condition in which a guy is powerless to achieve an erection. At least half populations of the men are suffering from the problem of erectile dysfunction. Inactive lifestyle of men, smoking, drinking of alcohol, obesity, stress, and tensions are the main reasons are responsible for the initiation of ED. Most of the men feel shy to discuss the problem with their partner and doctor.

The global environmental monitoring market is poised to grow at a CAGR of 7.5% during 2015-2020, and is expected to reach a value of $20.5 Billion in 2020. A number of factors such as growing global population, development of policies and initiatives aimed to reduce air, soil, and water pollution, increasing government funding towards pollution prevention and control, growing construction of environmental monitoring stations, growing initiative towards the development of environment-friendly industries, and reduction in export tariff on environmental monitoring technologies in emerging and developed markets are fuelling the growth of the global market

Market Overview: Next-generation antibody therapeutics includes the use of new improvised therapeutic antibody to form innovative medicines for treating various diseases. Next-generation antibody therapeutics is developed clinically by pharmaceutical and biotechnology companies for several diseases. The Next Generation Antibody Therapeutics Market size was worth $ XX million in 2018 and is forecasted to reach $ XX million by 2026, expected to grow at a high CAGR during the forecast period 2019-2026. Market Dynamics: The Next Generation Antibody Therapeutics Market is growing due to several factors such as rising incidence of chronic diseases, increasing emergence of antibody technology, new drug discovery, large number of government initiatives, and growing research and development activities for new therapies. Rising prevalence of chronic disease such as cancer, asthma, diabetes and COPD are boosting the growth of the next generation antibody therapeutics market. For instance, according to National Cancer Institute in 2018, in United States, an estimated 1,735,350 new cases of cancer will be diagnosed and 609,640 people will die from the disease. The development of next-generation monoclonal antibodies has expanded beyond oncology into all therapeutic areas. For instance, ADCs were initially focused primarily on cancer, but Genentech has applied to infectious diseases, leading to the discovery and development of THIOMAB antibiotic conjugates (TACs) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). The technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, hence, driving the growth in the next-generation antibody therapeutics market. However, stringent government regulation, high cost and time required for research and development activities are some of the factors hindering the growth for global next-generation antibody therapeutics market. Market Segmentation: Based o